Profil
Sarah J.
Alexander served as an Independent Director at NewLink Genetics Corp.
from 2012 to 2012.
Prior to that, she obtained a doctorate degree from Emory University.
Anciens postes connus de Sarah J. Alexander
| Sociétés | Poste | Fin |
|---|---|---|
| LUMOS PHARMA, INC. | Directeur/Membre du Conseil | 02/11/2012 |
Formation de Sarah J. Alexander
| Emory University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |